当地时间10月7日，瑞典皇家科学院决定将2025年诺贝尔物理学奖授予约翰·克拉克、米歇尔·H·德沃雷和约翰·M·马蒂尼斯三名量子物理学家，以表彰他们在电路中实现宏观量子力学隧穿效应和能量量子化方面的贡献。量子力学在1925年诞生，今年正值百年，诺贝尔物理学委员会主席奥勒·埃里克松当天表示，百年来量子力学不断带来新的惊喜，它大有用处，为数字技术提供了基础。

In this episode, host Laura Hart chats with Ask Nordestgaard about the long-term risk of stroke in healthy women, the role of inflammation and lipoproteins, and how early biomarker screening could transform stroke prevention strategies.

CME credits: 0.75Valid until: 07-10-2026 Claim your CME credit at https://reachmd.com/programs/cme/Understanding-Endocrine-Resistance-in-HR-HER2-mBC/37323/ The PI3K-AKT-mTOR pathway is a crucial signaling network dysregulated in many cancers, promoting cell survival, growth, and proliferation, and often implicated in resistance to cancer therapies. Inhibition of this pathway by PI3K inhibitors disrupts a complex network of cellular processes that contribute to breast cancer, markedly

CME credits: 0.75 Valid until: 07-10-2026 Claim your CME credit at https://reachmd.com/programs/cme/PI3K-Pathway-inhibition-in-HR-HER2-mBC-Mechanistic-Insights/37329/ The PI3K-AKT-mTOR pathway is a crucial signaling network dysregulated in many cancers, promoting cell survival, growth, and proliferation, and often implicated in resistance to cancer therapies. Inhibition of this pathway by PI3K inhibitors disrupts a complex network of cellular processes that contribute to breast cancer,

CME credits: 0.75 Valid until: 07-10-2026 Claim your CME credit at https://reachmd.com/programs/cme/Comprehensive-Biomarker-Testing-in-mBC-Informs-Clinical-Decision-Making/37332/ The PI3K-AKT-mTOR pathway is a crucial signaling network dysregulated in many cancers, promoting cell survival, growth, and proliferation, and often implicated in resistance to cancer therapies. Inhibition of this pathway by PI3K inhibitors disrupts a complex network of cellular processes that contribute to breast

CME credits: 0.75 Valid until: 07-10-2026 Claim your CME credit at https://reachmd.com/programs/cme/Double-Take-Pivotal-Data-Evaluating-PI3K-Inhibitor-Endocrine-Therapy-Regimens-in-mBC/37333/ The PI3K-AKT-mTOR pathway is a crucial signaling network dysregulated in many cancers, promoting cell survival, growth, and proliferation, and often implicated in resistance to cancer therapies. Inhibition of this pathway by PI3K inhibitors disrupts a complex network of cellular processes that

CME credits: 0.75 Valid until: 07-10-2026 Claim your CME credit at https://reachmd.com/programs/cme/Triple-Threat-Key-Data-on-Simultaneous-Estrogen-CDK4-6-and-PI3K-Inhibition-in-mBC/37335/ The PI3K-AKT-mTOR pathway is a crucial signaling network dysregulated in many cancers, promoting cell survival, growth, and proliferation, and often implicated in resistance to cancer therapies. Inhibition of this pathway by PI3K inhibitors disrupts a complex network of cellular processes that contribute

CME credits: 0.75 Valid until: 07-10-2026 Claim your CME credit at https://reachmd.com/programs/cme/Case-in-Point-Applying-PI3K-Combinations-in-Early-Recurrent-HR-HER2-mBC/37336/ The PI3K-AKT-mTOR pathway is a crucial signaling network dysregulated in many cancers, promoting cell survival, growth, and proliferation, and often implicated in resistance to cancer therapies. Inhibition of this pathway by PI3K inhibitors disrupts a complex network of cellular processes that contribute to breast

CME credits: 0.75 Valid until: 07-10-2026 Claim your CME credit at https://reachmd.com/programs/cme/PI3K-Pathway-Inhibitors-Safety-and-Tolerability-Profiles/37338/ The PI3K-AKT-mTOR pathway is a crucial signaling network dysregulated in many cancers, promoting cell survival, growth, and proliferation, and often implicated in resistance to cancer therapies. Inhibition of this pathway by PI3K inhibitors disrupts a complex network of cellular processes that contribute to breast cancer,

CME credits: 0.75 Valid until: 07-10-2026 Claim your CME credit at https://reachmd.com/programs/cme/The-Future-of-PI3K-Inhibition-in-HR-HER2-Breast-Cancer/37339/ The PI3K-AKT-mTOR pathway is a crucial signaling network dysregulated in many cancers, promoting cell survival, growth, and proliferation, and often implicated in resistance to cancer therapies. Inhibition of this pathway by PI3K inhibitors disrupts a complex network of cellular processes that contribute to breast cancer, markedly

First after LG elections but recorded before the results were known – From the ”can you believe it?” files: beer and cattle decarbonise each other – The answer lies in the soil: a Country Life special – “The Ends of the World” and amazing not so new book I couldn’t put down – “The Walrus Movement”: an unexpected reality check from Nate Hagens – Energy from heaven not hell: Bill McKibben on photovoltaics – a deeper dive on fossil fuel percentages https://climatemattersnz.substack.com/

Robert Michaud et Morgan Tidière font le point sur la sage des bélugas de Marineland menacés d'euthanasie; et Gino Harel, Renaud Manuguerra-Gagné ainsi qu'Alexandre Touchette présentent les lauréats du prix Nobel en médecine et en physique pour l'année 2025.

Dotée d'une force surhumaine et d'une intelligence fulgurante, l'IA Ares veut désormais… vivre. Fiction ou futur proche ?

Dr. Barry Dworkin takes your phone calls and health questions on this Thanksgiving Sunday. But first, we tackle the waiting lists that continue to balloon across the country, and the potential solutions we should be using to fix them.

For Dear Science this week, our expert, Dr Cushla McGoverin talks with us about the Nobel prizes in Physiology or Medicine, Chemistry, and Physics.Love all things trams? LIVE Day: Trams is on at MOTAT this Sunday 19 October! Check out their impressive collection and catch a ride on one of the steam trains. Thanks to MOTAT, the museum inspiring the innovators of tomorrow.

Previsioni meteo Toscana del 13-10-2025

Previsioni meteo Toscana del 13-10-2025

Eye On The Night Sky For Monday, October 13

Женский мочевой пузырь меньше мужского, а еще женщины больше нуждаются в жировой ткани и могут носить в организме ДНК своего ребенка долгое время после родов. И это еще не все удивительные факты о женском организме, которые вы узнаете из этого выпуска. Позаботьтесь о себе и пройдите гинекологический чек-ап в «СМ-Клиника»: https://clck.ru/3P2tQG Имеются противопоказания. Посоветуйтесь со специалистом. Редактор — Юлия Зайкова; Звукорежиссёр — Андрей Деркач; Ведущая — Диана Малечева; Автор текста

عناوين النشرة العلمية : - ثلاثي من علماء الكيمياء ينال جائزة نوبل في الكيمياء لعام 2025 من بينهم الأردني الأميركي عمر مونّس ياغي   - النساء أكثر عرضة من الرجال للإصابة باضطرابات الاكتئاب والأسباب هي وراثية بحسب دراسة أسترالية - الاتحاد الأوروبي يخصّص نحو مليار يورو لتوسيع استعمال تقنيات الذكاء الاصطناعي في قطاعي الصناعة والعلوم   على غرار الفائزين الثلاث بجائزة نوبل في الفيزياء، نال جائزة نوبل في الكيمياء لعام 2025 ثلاثي يضمّ الأردني الأميركي عمر مونّس ياغي والياباني Susumu Kitagawa والبريطاني